# DECITABINE
> **ANDA210984** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2019-09-16
## Drug
- **FDA Application Number:** ANDA210984
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DECITABINE
- **Generic name:** DECITABINE
- **Active ingredients:** DECITABINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** NOVAST LABS
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 2019-09-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210984)
---
*AI Analytics · CC0 1.0*